These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12624072)

  • 21. Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi.
    Wilske B; Preac-Mursic V; Jauris S; Hofmann A; Pradel I; Soutschek E; Schwab E; Will G; Wanner G
    Infect Immun; 1993 May; 61(5):2182-91. PubMed ID: 8478108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization and expression of p23 (OspC) from a North American strain of Borrelia burgdorferi.
    Padula SJ; Sampieri A; Dias F; Szczepanski A; Ryan RW
    Infect Immun; 1993 Dec; 61(12):5097-105. PubMed ID: 8225587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of recombinant line immunoblot for detection of Lyme disease in Slovakia: comparison with two other immunoassays.
    Lencáková D; Fingerle V; Stefancíková A; Schulte-Spechtel U; Petko B; Schréter I; Wilske B
    Vector Borne Zoonotic Dis; 2008 Jun; 8(3):381-90. PubMed ID: 18279004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule.
    Embers ME; Jacobs MB; Johnson BJ; Philipp MT
    Clin Vaccine Immunol; 2007 Aug; 14(8):931-6. PubMed ID: 17567769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.
    Panelius J; Lahdenne P; Heikkilä T; Peltomaa M; Oksi J; Seppälä I
    J Med Microbiol; 2002 Sep; 51(9):731-739. PubMed ID: 12358063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral immune response associated with lyme borreliosis in nonhuman primates: analysis by immunoblotting and enzyme-linked immunosorbent assay with sonicates or recombinant proteins.
    Pachner AR; Dail D; Li L; Gurey L; Feng S; Hodzic E; Barthold S
    Clin Diagn Lab Immunol; 2002 Nov; 9(6):1348-55. PubMed ID: 12414773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Enzyme immunoassay-based analysis of OspC recombinant proteins from Borrelia garinii and Borrelia afzelii isolated in West Siberia].
    Karavaev VS; Riabchenko AV; Beklemishev AB
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (1):20-3. PubMed ID: 20218339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of an internally controlled real-time PCR targeting the ospA gene for detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid.
    Gooskens J; Templeton KE; Claas EC; van Dam AP
    Clin Microbiol Infect; 2006 Sep; 12(9):894-900. PubMed ID: 16882295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Western-blot with VLSE protein and "in vivo" antigens in Lyme borreliosis diagnosis].
    Zajkowska J; Kondrusik M; Pancewicz S; Grygorczuk S; Swierzbińska R; Hermanowska-Szpakowicz T; Czeczuga A; Sienkiewicz I
    Przegl Epidemiol; 2006; 60 Suppl 1():177-85. PubMed ID: 16909799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune responses to borrelial VlsE IR6 peptide variants.
    Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
    Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.
    Peltomaa M; McHugh G; Steere AC
    Otol Neurotol; 2004 Sep; 25(5):838-41. PubMed ID: 15354020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.
    Wilske B; Fingerle V; Herzer P; Hofmann A; Lehnert G; Peters H; Pfister HW; Preac-Mursic V; Soutschek E; Weber K
    Med Microbiol Immunol; 1993 Nov; 182(5):255-70. PubMed ID: 8283961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.
    Wilske B; Jauris-Heipke S; Lobentanzer R; Pradel I; Preac-Mursic V; Rössler D; Soutschek E; Johnson RC
    J Clin Microbiol; 1995 Jan; 33(1):103-9. PubMed ID: 7699024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
    Dickeson DJ; Chen SC; Sintchenko VG
    Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of multiplexing technology to the analysis of the intrathecally released immunoglobulins against B. burgdorferi antigens in neuroborreliosis.
    Zajkowska J; Lelental N; Kulakowska A; Mroczko B; Pancewicz S; Bucki R; Kornhuber J; Lewczuk P
    Immunol Lett; 2015 Nov; 168(1):58-63. PubMed ID: 26210581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of diagnostic approach to Lyme neuroborreliosis in children by using recombinant antigens in detection of intrathecally produced IgM/IgG.
    Krbková L; Bednářová J; Čermáková Z
    Epidemiol Mikrobiol Imunol; 2016; 65(2):112-7. PubMed ID: 27467328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme-linked immunosorbent assay, immunofluorescent assay, and recombinant immunoblotting in the serodiagnosis of early Lyme borreliosis.
    Christova I
    Int J Immunopathol Pharmacol; 2003; 16(3):261-8. PubMed ID: 14611730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of the immunodominant surface protein VlsE among the three genospecies of Borrelia burgdorferi pathogenic for humans.
    Göttner G; Schulte-Spechtel U; Wilske B
    Int J Med Microbiol; 2004 Apr; 293 Suppl 37():172-3. PubMed ID: 15147003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.